Literature DB >> 12694773

Ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve: involvement and clinical relevance of smooth muscle cell apoptosis and expression of cell death-initiating proteins.

Franz-Xaver Schmid1, Katrin Bielenberg, Anette Schneider, Andreas Haussler, Andreas Keyser, Dietrich Birnbaum.   

Abstract

OBJECTIVE: There is relationship between a dilated ascending aorta and a bicuspid aortic valve. Controversy exists concerning techniques available for surgical restoration of the functional and anatomical integrity of the aortic root. The present study was undertaken to define the histopathologic and molecular biologic condition of ascending aortic aneurysms associated with bicuspid (BAV) or tricuspid aortic valve (TAV) and the relationship to valve sparing or pulmonary autograft procedures.
METHODS: Aortic aneurysm wall specimens from 20 patients (10 BAV; 10 TAV) undergoing elective repair and normal aortic tissues from organ donors (n=5) were analysed for patterns of smooth muscle cells (SMCs) and infiltrating leukocytes (immunohistochemistry), apoptosis (in situ end-labelling of DNA-fragments (TUNEL)), and expression of the death-promoting proteins perforin, Fas, and FasLigand (Immunoblotting).
RESULTS: Segments from aneurysms exhibited a distinct pattern of medial destruction, elastic fragmentation, and disorientation with rarefication of SMCs. BAV wall segments contained more cells bearing markers of apoptosis than TAV specimens whereas normal aorta displayed only few apoptotic cells (P<0.05). TUNEL showed higher levels of DNA fragmentation in BAV than in TAV, and double immunostaining identified SMCs as the principal cell type displaying fragmented DNA. Immunohistochemistry confirmed expression of death-promoting mediators by infiltrating lymphocytes, and Western blotting documented their presence in BAV and TAV aneurysmal tissue, with the greatest increases seen in specimens from aneurysms associated with BAV.
CONCLUSIONS: There is evidence for a molecular link between SMC apoptosis initiated by infiltration and local signal expression of immune cells and weakening of the aortic wall being more prevalent in patients with BAV. Our findings may suggest a mechanism responsible for aneurysm formation of the aorta and aortic dilatation after autograft root or sinus remodelling procedures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12694773     DOI: 10.1016/s1010-7940(02)00833-3

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  20 in total

1.  Unraveling divergent gene expression profiles in bicuspid and tricuspid aortic valve patients with thoracic aortic dilatation: the ASAP study.

Authors:  Lasse Folkersen; Dick Wågsäter; Valentina Paloschi; Veronica Jackson; Johan Petrini; Sanela Kurtovic; Shohreh Maleki; Maria J Eriksson; Kenneth Caidahl; Anders Hamsten; Jean-Baptiste Michel; Jan Liska; Anders Gabrielsen; Anders Franco-Cereceda; Per Eriksson
Journal:  Mol Med       Date:  2011-09-27       Impact factor: 6.354

2.  Chronic mTOR activation induces a degradative smooth muscle cell phenotype.

Authors:  Guangxin Li; Mo Wang; Alexander W Caulk; Nicholas A Cilfone; Sharvari Gujja; Lingfeng Qin; Pei-Yu Chen; Zehua Chen; Sameh Yousef; Yang Jiao; Changshun He; Bo Jiang; Arina Korneva; Matthew R Bersi; Guilin Wang; Xinran Liu; Sameet Mehta; Arnar Geirsson; Jeffrey R Gulcher; Thomas W Chittenden; Michael Simons; Jay D Humphrey; George Tellides
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

3.  Circulating soluble receptor for advanced glycation end product identifies patients with bicuspid aortic valve and associated aortopathies.

Authors:  Emanuela Branchetti; Joseph E Bavaria; Juan B Grau; Richard E Shaw; Paolo Poggio; Eric K Lai; Nimesh D Desai; Joseph H Gorman; Robert C Gorman; Giovanni Ferrari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-08-14       Impact factor: 8.311

4.  Bicuspid aortic valve and aortic root disease.

Authors:  Artur Evangelista
Journal:  Curr Cardiol Rep       Date:  2011-06       Impact factor: 2.931

Review 5.  Multimodality imaging assessment of bicuspid aortic valve disease, thoracic aortic ectasia, and thoracic aortic aneurysmal disease.

Authors:  Preethi Mani; Reza Reyaldeen; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

Review 6.  Open Versus Endovascular or Hybrid Thoracic Aortic Aneurysm Repair.

Authors:  Ryan Clare; Julianne Jorgensen; Somjot S Brar
Journal:  Curr Atheroscler Rep       Date:  2016-10       Impact factor: 5.113

7.  Basal and oxidative stress-induced expression of metallothionein is decreased in ascending aortic aneurysms of bicuspid aortic valve patients.

Authors:  Julie A Phillippi; Ekaterina A Klyachko; John P Kenny; Michael A Eskay; Robert C Gorman; Thomas G Gleason
Journal:  Circulation       Date:  2009-04-27       Impact factor: 29.690

8.  Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm.

Authors:  Emanuela Branchetti; Paolo Poggio; Rachana Sainger; Eric Shang; Juan B Grau; Benjamin M Jackson; Eric K Lai; Michael S Parmacek; Robert C Gorman; Joseph H Gorman; Joseph E Bavaria; Giovanni Ferrari
Journal:  Cardiovasc Res       Date:  2013-08-28       Impact factor: 10.787

9.  Proteomic alterations in heat shock protein 27 and identification of phosphoproteins in ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve.

Authors:  Peter Matt; Zongming Fu; Thierry Carrel; David L Huso; Stefan Dirnhofer; Ivan Lefkovits; Hans-Reinhard Zerkowski; Jennifer E Van Eyk
Journal:  J Mol Cell Cardiol       Date:  2007-08-28       Impact factor: 5.000

10.  Quantitative not qualitative histology differentiates aneurysmal from nondilated ascending aortas and reveals a net gain of medial components.

Authors:  Sameh Yousef; Nana Matsumoto; Issam Dabe; Makoto Mori; Alden B Landry; Shin-Rong Lee; Yuki Kawamura; Chen Yang; Guangxin Li; Roland Assi; Prashanth Vallabhajosyula; Arnar Geirsson; Gilbert Moeckel; Jay D Humphrey; George Tellides
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.